Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott Laboratories (ABT) and Linde plc (LIN), as well as a micro-cap stock Tredegar Corp. (TG).

In 2024, Abbott obtained FDA approvals for two new over-the-counter CGM systems called Lingo and Libre Rio, based on Libre’s technology, which is now used by more than 6 million people around ...

In a relatively short span, FreeStyle Libre has achieved global leadership among continuous glucose monitoring (CGM) systems ...

In a relatively short span, FreeStyle Libre has achieved global leadership among continuous glucose monitoring (CGM) systems for both ... called Lingo and Libre Rio, which are based on Libre ...

Researchers at the University of Bath in Bath, England, evaluated glycemic responses in healthy volunteers with normal body mass index using two methods: A CGM device (Abbott Freestyle Libre 2 ...

In a relatively short span, FreeStyle Libre has achieved global leadership among continuous glucose monitoring (CGM) systems for both ... called Lingo and Libre Rio, which are based on Libre ...

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2025 amid foreign exchange ...

Por Redacción PortalPortuario @PortalPortuario La naviera CMA CGM presentó su primer buque que navegará con el pabellón de ...